Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 478

1.

Pharmacokinetics and pharmacodynamics of conjugated equine estrogens: chemistry and metabolism.

Bhavnani BR.

Proc Soc Exp Biol Med. 1998 Jan;217(1):6-16. Review.

PMID:
9421201
3.

Pharmacokinetics and pharmacodynamics of a novel estrogen delta8-estrone in postmenopausal women and men.

Bhavnani BR, Cecutti A, Gerulath A.

J Steroid Biochem Mol Biol. 1998 Oct;67(2):119-31.

PMID:
9877212
4.

Equine estrogens differentially prevent neuronal cell death induced by glutamate.

Bhavnani BR, Berco M, Binkley J.

J Soc Gynecol Investig. 2003 Jul;10(5):302-8.

PMID:
12853093
5.

Comparison of pharmacokinetics of a conjugated equine estrogen preparation (premarin) and a synthetic mixture of estrogens (C.E.S.) in postmenopausal women.

Bhavnani BR, Nisker JA, Martin J, Aletebi F, Watson L, Milne JK.

J Soc Gynecol Investig. 2000 May-Jun;7(3):175-83.

PMID:
10865186
6.

Pharmacokinetics of 17 beta-dihydroequilin sulfate in normal postmenopausal women under steady state conditions.

Bhavnani BR, Cecutti A, Gerulath A.

J Soc Gynecol Investig. 2002 Mar-Apr;9(2):102-10.

PMID:
12398033
7.

Metabolism of equilin sulfate in the dog.

Chandrasekaran A, Osman M, Scatina JA, Sisenwine SF.

J Steroid Biochem Mol Biol. 1995 Nov;55(2):271-8.

PMID:
7495708
8.
9.
10.

Structure activity relationships and differential interactions and functional activity of various equine estrogens mediated via estrogen receptors (ERs) ERalpha and ERbeta.

Bhavnani BR, Tam SP, Lu X.

Endocrinology. 2008 Oct;149(10):4857-70. doi: 10.1210/en.2008-0304. Epub 2008 Jul 3.

PMID:
18599548
11.
12.
13.

Effect of halogenated substituents on the metabolism and estrogenic effects of the equine estrogen, equilenin.

Liu X, Zhang F, Liu H, Burdette JE, Li Y, Overk CR, Pisha E, Yao J, van Breemen RB, Swanson SM, Bolton JL.

Chem Res Toxicol. 2003 Jun;16(6):741-9.

PMID:
12807357
14.

Pharmacokinetics of 17 beta-dihydroequilin sulfate and 17 beta-dihydroequilin in normal postmenopausal women.

Bhavnani BR, Cecutti A.

J Clin Endocrinol Metab. 1994 Jan;78(1):197-204.

PMID:
8288704
15.
16.
17.

Modification of serum lipids and cardiovascular risk by estrogenic active compounds.

Windler E.

Gynecol Endocrinol. 1999 Dec;13 Suppl 6:21-8. Review.

PMID:
10862265
19.
20.

Pharmacology of conjugated equine estrogens: efficacy, safety and mechanism of action.

Bhavnani BR, Stanczyk FZ.

J Steroid Biochem Mol Biol. 2014 Jul;142:16-29. doi: 10.1016/j.jsbmb.2013.10.011. Epub 2013 Oct 28. Review.

PMID:
24176763

Supplemental Content

Support Center